Navigation Links
Nutraceutical International Corporation Launches Product Featuring ChromaDex's pTeroPure™ Pterostilbene
Date:3/30/2011

IRVINE, Calif., March 30, 2011 /PRNewswire/ -- ChromaDex (OTC Bulletin Board: CDXC) today announced that Nutraceutical International Corporation (Nasdaq: NUTR), one of the nation's largest manufacturers of nutritional supplements, has launched a product featuring ChromaDex's pTeroPure™ Pterostilbene in its Solaray® Guaranteed Potency line of products.

Solaray Super Resveratrol with Pterostilbene is a product that combines the proven benefits of resveratrol with the high potency, elevated cellular absorption and peer-reviewed scientific research of pterostilbene. Published reports have shown pterostilbene and resveratrol to be synergistic in protecting cells from damage caused by oxidative stress.  pTeroPure Pterostilbene is 99+% pure and superior to other marketed stilbenes due to its sustainable sourcing and ultra-high purity.  In addition to 250 mg of resveratrol and 25 mg of pterostilbene, Solaray Super Resveratrol with Pterostilbene also provides grape skin and grape seed extracts.  The product is now available through domestic health and natural food stores nationwide.  Search for a store near you using the customer gateway at http://www.nutraceutical.com .

"The launch of this new dietary supplement demonstrates the continued growth of pTeroPure and the rising demand for pTeroPure across the dietary supplements market," remarked Jeremy Bartos, Ph.D., ChromaDex's pTeroPure Product Manager.  "Partnerships such as the one with Nutraceutical Corporation allow us to leverage our collaborators' market expertise, reputation, and distinct sales forces to increase the presence of pTeroPure in the marketplace."  

About Nutraceutical International Corporation

Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores.  The company's core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements.   This includes providing nutritional supplements and other natural products under numerous brands including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, bioAllers®, Herbs for Kids™, NaturalCare®, Health from the Sun®, Life-flo®, Organix South®, Pioneer® and Monarch Nutraceuticals™. Nutraceutical International Corporation is a publicly-traded life-sciences company (NASDAQ: NUTR).

About ChromaDex

ChromaDex™ is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries.  The company has an impressive pipeline of new ingredients, including its pTeroPure™ pterostilbene on which it has worldwide, exclusive patent rights.  ChromaDex is a publicly-traded life-sciences company (OTC stock symbol CDXC.OB)

ChromaDex Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Nutraceutical Contact:
Scott Smith
Specialty Products Brand Manager: Solaray®
1500 Kearns Blvd, Second Floor
Park City, UT 84060
435-655-6000
sjsmith@nutracorp.com

ChromaDex Investor Inquiries:
Liviakis Financial Communications, Inc.
John M. Liviakis, President
415-389-4670
John@Liviakis.com

ChromaDex Contact
Jenny Robles
Administrative Assistant to the CEO and the President
10005 Muirlands Blvd, Suite G, Irvine, CA 92618
949-419-0288
jennyr@chromadex.com

Media Inquiries:
Carolyn Hawley
Canale Communications
4010 Goldfinch St., San Diego, CA, 92103
619-849-5375
carolyn@canalecomm.com


'/>"/>
SOURCE ChromaDex
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ScienceBased Health and Hoya Surgical Optics, Inc. Combine Forces to Expand Reach of Evidence-Based Nutraceuticals in Ophthalmic Market and Enhance Patient Care
2. Reportlinker Adds Global Nutraceuticals Industry
3. Reportlinker Adds Nutraceutical Market
4. Nutraceutical Leader Announces Internal Promotions of Key Personnel
5. PRA International Experts to Chair BioPharma Asia Panels
6. HeartWare International Receives Approval From the Therapeutic Goods Administration (TGA) in Australia
7. PRA International Experts to Speak at Industry Events
8. Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule
9. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2010
10. International Medical Corps Team in Hardest-Hit Coastal Communities Finds Severe Shortages of Food, Water, Medicines; Acute Need for Mental Health Support
11. Pharmaceutics International Inc. (Pii) Announces Appointment of Rampurna Prasad Gullapalli, Ph.D. as Vice President of Drug Delivery Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... February 17, 2017 On Thursday, ... 500 edged lower at the closing bell, while the ... the 20,000 benchmark. Moreover, five out of nine sectors ... consideration yesterday,s market sentiment, Stock-Callers.com assessed the following Medical ... PLC (NYSE: SNN ), ABIOMED Inc. (NASDAQ: ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
(Date:2/16/2017)... Scripts (NASDAQ: ESRX ) was recognized today by Fortune ... Health Care: Pharmacy and Other Services category. "Express Scripts ... Companies," said Tim Wentworth , CEO and President, Express Scripts. ... 26,000 employees to make medicine more affordable and accessible for the ... ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow ... Tri-Conference February 20 – 22 in San Francisco. As part of the Tri-Conference ... molecular pathology workflow solution, as well as its new precision medicine platform, “Crosswalk ...
(Date:2/17/2017)... ... ... Top neuroendocrine cancer doctors, nurses and specialists from around the world will ... in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive director of ... hosting over 60 faculty members and addressing unmet needs of the NET community. ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... financial planning assistance to families and business owners in the greater Fort Lauderdale ... Families organization. , For more than 30 years, LifeNet 4 Families has ...
(Date:2/16/2017)... ... February 17, 2017 , ... For some cancer survivors, ... final treatments. Physician researchers at The Marcus Institute of Integrative Health at ... efficacy in reducing symptoms of traumatic stress in cancer patients and published ...
Breaking Medicine News(10 mins):